Johnson & Johnson has begun dosing up to 60,000 volunteers in a study of its Covid-19 vaccine, marking the first big U.S. trial of an inoculation that may work after just one shot. Bloomberg’s Robert Langreth reports on “Bloomberg Markets.”
Bloomberg Markets News video.
____________________
new York USA ECO BUSINESS EcoTechN.com
______________
NEW YORK MIDTOWN TRIBUNE NEWS POLITICS
BUSINESS SOCIETY CRIME CULTURE USA